Danielle Ferraro

Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial

Niall C. Tebbutt, Timothy Price, Danielle Ferraro et al. · British Journal of Cancer · 2016 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial

Andrew R. Davidson, A.-S. Veillard, Annette Tognela et al. · Annals of Oncology · 2015 · 33 citations

Medicine, Oncology, Pharmacology +13

Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition

Diar Aziz, Neil Portman, Kristine J. Fernandez et al. · npj Breast Cancer · 2021 · 18 citations · Full text

Medicine, Cancer Biology, Oncology +16

TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer

Danielle Ferraro, David Goldstein, Rachel O’Connell et al. · Cancer Chemotherapy and Pharmacology · 2016 · 16 citations · Full text

Medicine, Oncology, Pharmacology +13